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Abstract
Hepatic angiosarcoma is a rare malignant vascular tumor, which accounts for up to 2% of all primary
liver tumors. The most frequent symptoms on presentation are weight loss, weakness and abdominal
pain. Diagnosis of diffuse hepatic angiosarcoma can be challenging. We report an original case of
diffuse liver angiosarcoma revealed by haematological abnormalities initially diagnosed as an Evans
syndrome. Anaemia and thrombocytopenia are rarely the first manifestations of this pathology. They
are explained by combination of several mechanisms. Diagnosis of diffuse liver angiosarcoma can be
extremely difficult and physicians should be aware of these presentation.
Case presentation
A 47-year-old Caucasian man was referred to our depart-
ment for investigation of an anemia and thrombocytope-
nia in November 2005. He had been in his usual good
health until three months prior to his hospitalization
when he started to suffer from fatigue and progressive loss
of 15 kilograms. He worked in the aviation business and
he had traveled several times in Africa up to 1989. He did
not smoke or consume alcohol.
The patient had macrocytic anemia and thrombocytopenia.
The lactate dehydrogenase was 796 U/l and reticulocytes
260 G/l. Haptoglobin and ferritin levels were low. Hemo-
lysis work-up, including direct and indirect Coombs’ tests
was negative. No schizocyte and fibrin split product were
found. Myelogram showed no pathologic medullar infiltra-
tion. His liver function tests revealed a mixed cholestatic/
hepatitic abnormality. He had a low serum albumin and
elevated prothrombine time. Factor Vwas 67%andactivated
partial thromboplastin time was normal. Evaluation was
negative for viral hepatitis, hemochromatosis and Wilson’s
disease. The results of blood tests including alpha fetopro-
tein, fibrinogene level and autoantibodies were normal.
Abdominal ultrasonography revealed enlarged homoge-
nous liver, splenomegaly and moderate amount of ascites.
There were signs of portal hypertension in gastroscopy. A
steroid therapy was administrated for one month in
hypothesis of Evans syndrome unsuccessfully.
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Physic status worsened and denutrition, jaundice, hepa-
tosplenomegaly appeared. Ascites increased progressively.
The patient was then referred to our department.
Abdominal computed tomography (CT) showed ascites,
splenomegaly and heterogeneous liver nodules, filled with
contrast-like agent (Figure 1). Ascites puncture did not
isolate malignant cells. Bone marrow examination was not
contributory. Infectious disease such as tuberculosis,
leishmaniasis, HIV and intracellular germs infections
were eliminated. A first transjugular liver biopsy showed
a centrolobular lesion with an appearance of myeloid
metaplasia but interpretation was difficult because of the
small size of the biopsy. The patient underwent then an
exploratory laparotomy. Splenic histology was normal and
the liver biopsy was not contributive since hemorrhagic. A
new abdominal CT showed an increase of the liver
nodules size. A second transjugular liver biopsy was then
performed and histologic examination and immunohis-
tochemistry were consistent with primary hepatic angio-
sarcoma. We did not start any active treatment because
patient’s conditions were poor. He died three months after
initial presentation in hepatic failure.
Hepatic angiosarcoma is a rare malignant vascular tumor,
which accounts for up to 2% of all primary liver tumors.
Aetiologic factors, absent in our case, are exposure to
thorium dioxide, polyvinyl chloride and arsenic. The most
frequent symptoms on presentation are weight loss,
weakness and abdominal pain [1]. Physical findings
include ascites, hepatomegaly and jaundice. It is unusual
that liver angiosarcoma is revealed by haematological
abnormalities. [2]. Anaemia and thrombocytopenia may
be related tomicroangiopathic haemolytic anemia, systemic
disseminated coagulation, bleeding due to portal hyperten-
sion or hemoperitoneum, hypersplenism or, as in our case,
combination of several mechanisms [1]: low ferritin and
haptoglobin levels with no signs of chronic bleeding in
gastroscopy or CT led to the diagnosis of intravascular
hemolysis associated with portal hypertension. Classical CT
findings are single or multiples hypoattenuating masses
with heterogeneous enhancement on contrast-enhanced CT
[1-3]. More rarely, diffuse liver angiosarcomamay appear as
pseudo-peliosis with diffusely infiltrating micronodules,
filledwith contrast-like agent [3]. In these cases, diagnosis of
diffuse liver angiosarcoma can be extremely difficult and
liver biopsy has been reported as treacherous and non
diagnostic [1]. The prognosis for patients with primary
angiosarcoma of the liver is very poor with a median
survival reported to be around 6 months [4].
Conclusion
In summary, diagnosis of diffuse hepatic angiosarcoma
can be challenging. Physicians should be aware of this
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